Terms: = Sarcomas AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
420 results:
1. Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
Roohani S; Ehret F; Beck M; Veltsista DP; Nadobny J; Zschaeck S; Abdel-Rahman S; Eckert F; Flörcken A; Issels RD; Klöck S; Krempien R; Lindner LH; Notter M; Ott OJ; Pink D; Potkrajcic V; Reichardt P; Riesterer O; Spałek MJ; Stutz E; Wessalowski R; Zilli T; Zips D; Ghadjar P; Kaul D
Int J Hyperthermia; 2024; 41(1):2342348. PubMed ID: 38653548
[TBL] [Abstract] [Full Text] [Related]
2. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning radiomics-based prediction model of metachronous distant metastasis following curative resection for retroperitoneal leiomyosarcoma: a bicentric study.
Tian Z; Cheng Y; Zhao S; Li R; Zhou J; Sun Q; Wang D
Cancer Imaging; 2024 Apr; 24(1):52. PubMed ID: 38627828
[TBL] [Abstract] [Full Text] [Related]
4. A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.
Li X; Shi X; Wang Y; Pang J; Zhao X; Xu Y; Li Q; Wang N; Duan F; Nie P
Cancer Imaging; 2024 Apr; 24(1):50. PubMed ID: 38605380
[TBL] [Abstract] [Full Text] [Related]
5. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
6. Post Renal Transplant Malignancies; A Basic Concept.
Nabi Z; Zahid T; Nabi R
J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
[TBL] [Abstract] [Full Text] [Related]
7. [Parosteal osteosarcoma of the femur and salvage surgery with intercalary prosthesis. Experience in a third level unit and surgical technique].
Vilchis-Ramírez M; Álvarez-Martínez FA; Tena-Sanabria ME; Fuentes-Herrera G
Acta Ortop Mex; 2023; 37(5):309-313. PubMed ID: 38382457
[TBL] [Abstract] [Full Text] [Related]
8. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic characteristics of a six-gene signature based on ssGSEA in sarcoma.
Liu J; Lu J; Wang G; Gu L; Li W
Aging (Albany NY); 2024 Jan; 16(2):1536-1554. PubMed ID: 38240704
[TBL] [Abstract] [Full Text] [Related]
11. A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning.
Aslam M; Rajbdad F; Azmat S; Li Z; Boudreaux JP; Thiagarajan R; Yao S; Xu J
Comput Methods Programs Biomed; 2024 Mar; 245():108019. PubMed ID: 38237450
[TBL] [Abstract] [Full Text] [Related]
12. Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal Tumors.
Sierra ED; Valenzuela R; Canjirathinkal MA; Costelloe CM; Moradi H; Madewell JE; Murphy WA; Amini B
JCO Clin Cancer Inform; 2024 Jan; 8():e2300118. PubMed ID: 38181324
[TBL] [Abstract] [Full Text] [Related]
13. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy.
Zhou Z; Lin Z; Wang M; Wang L; Ji Y; Yang J; Yang Y; Zhu G; Liu T
Eur J Med Res; 2024 Jan; 29(1):12. PubMed ID: 38173048
[TBL] [Abstract] [Full Text] [Related]
14. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
[TBL] [Abstract] [Full Text] [Related]
15. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract] [Full Text] [Related]
16. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract] [Full Text] [Related]
17. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
18. The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.
Yang S; Liu L; Liu X; Li X; Zheng Y; Ren Z; Wang R; Wang Y; Li Q
Medicine (Baltimore); 2023 Nov; 102(46):e36046. PubMed ID: 37986397
[TBL] [Abstract] [Full Text] [Related]
19. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
Dodin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
[TBL] [Abstract] [Full Text] [Related]
20. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
[TBL] [Abstract] [Full Text] [Related]
[Next]